Concepedia
Statistics
Publications
12
Citations
4.2K
H-Index
Active since
2006
Affiliations
AbbVie (United States)(Current)
The University of Melbourne
Walter and Eliza Hall Institute of Medical Research
Purdue University West Lafayette
Nathaniel D. Catron is an author at AbbVie (United States) specializing in pharmacology, pharmacy, and drug delivery.
Publications per year
2006–2024
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers, Joel D. Leverson, Erwin R. Boghaert et al. · Nature Medicine · 2013 · 3K citations
Medicine, Oncology, Pharmacology +10
Discovery of a Potent and Selective BCL-X <sub>L</sub> Inhibitor with <i>in Vivo</i> Activity
Zhi‐Fu Tao, Lisa Hasvold, Le Wang et al. · ACS Medicinal Chemistry Letters · 2014 · 331 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +10
Enhancements and Limits in Drug Membrane Transport Using Supersaturated Solutions of Poorly Water Soluble Drugs
Shweta A. Raina, Geoff G. Z. Zhang, David E. Alonzo et al. · Journal of Pharmaceutical Sciences · 2013 · 188 citations · Full text
Pharmacy, Pharmaceutics, Pharmacology +12
Souers AJ, Leverson JD, Boghaert ER et al.ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med 19:202-208
Andrew J. Souers, Erwin R. Boghaert, Scott Ackler et al. · 2013 · 182 citations
Medicine, Oncology, Pharmacology +8
Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-X<sub>L</sub> Inhibitor
Le Wang, George Doherty, Andrew S. Judd et al. · ACS Medicinal Chemistry Letters · 2020 · 136 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +16
1–5 of 12